Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020070599 - NEBULIZATION COMPOSITION OF MOMETASONE

Publication Number WO/2020/070599
Publication Date 09.04.2020
International Application No. PCT/IB2019/058212
International Filing Date 27.09.2019
IPC
A61K 31/58 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopentahydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
58containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin
A61K 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
CPC
A61K 31/58
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
58containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
A61K 47/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 9/0078
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
007Pulmonary tract; Aromatherapy
0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;
0078for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
A61K 9/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
10Dispersions; Emulsions
Applicants
  • GLENMARK SPECIALTY S.A. [CH]/[CH]
  • MURUGAN, Ramprasad [IN]/[IN]
Inventors
  • MURUGAN, Ramprasad
  • DHUPPAD, Ulhas
  • RASE, Sagar
Priority Data
20182103774105.10.2018IN
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NEBULIZATION COMPOSITION OF MOMETASONE
(FR) COMPOSITION DE NÉBULISATION DE MOMÉTASONE
Abstract
(EN)
The present invention relates to a sterile pharmaceutical composition comprising mometasone or a pharmaceutically acceptable salt or ester thereof, for inhalation via nebulization to a subject. The invention also relates to a process of preparing the pharmaceutical composition and its use in the treatment of respiratory diseases in a subject.
(FR)
La présente invention concerne une composition pharmaceutique stérile comprenant de la mométasone ou un sel ou ester pharmaceutiquement acceptable de celle-ci, pour l'inhalation par nébulisation à un sujet. L'invention concerne également un procédé de préparation de la composition pharmaceutique et son utilisation dans le traitement de maladies respiratoires chez un sujet.
Latest bibliographic data on file with the International Bureau